|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.16 EUR | +1.87% |
|
-5.03% | -10.69% |
| 08-04 | European Stocks Close Higher Tuesday on Earnings Strength, Hormuz Talks | MT |
| 08-04 | Nurix Therapeutics Gets $10 Million Milestone Payment as Sanofi Initiates Phase 1 Trial of STAT6 Degrader | MT |
| Market Cap | 89.12B 103B 83.15B 76.4B 145B 9,802B 146B 978B 383B 4,890B 386B 377B 16,210B | P/E 2026 * |
12.2x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 100B 116B 93.75B 86.15B 163B 11,052B 164B 1,103B 432B 5,513B 435B 425B 18,277B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.91x |
| Free-Float |
89.21% | Yield 2026 * |
5.7% | Yield 2027 * | 6.05% |
Last Transcript: Sanofi
| 1 day | +1.87% | ||
| 1 week | -5.03% | ||
| 1 month | -2.15% | ||
| 3 months | -7.23% | ||
| 6 months | -8.58% | ||
| Current year | -10.69% |
| 1 week | 72.1 |  | 80.1 |
| 1 month | 72.1 | | 80.1 |
| Current year | 71.27 | | 84.9 |
| 1 year | 71.27 | | 93 |
| 3 years | 71.27 | | 111 |
| 5 years | 71.27 | | 111 |
| 10 years | 63.15 | | 111 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.87% | -5.03% | - | - | 103B | |
| -0.51% | -6.83% | +46.35% | +148.39% | 1T | |
| +0.20% | -4.14% | +52.35% | +49.40% | 613B | |
| -0.53% | -5.10% | +24.88% | +63.57% | 433B | |
| +0.48% | -0.67% | +39.13% | +34.00% | 350B | |
| +0.08% | -3.05% | +32.29% | +39.91% | 292B | |
| +2.09% | -8.91% | +5.73% | +7.71% | 239B | |
| +1.75% | -5.79% | -0.39% | -42.69% | 206B | |
| +2.94% | +3.66% | +31.37% | +69.06% | 204B | |
| +3.13% | +3.62% | +19.50% | +79.07% | 163B | |
| Average | +0.99% | -3.88% | +27.91% | +49.82% | 388.94B | |
| Weighted average by Cap. | +0.81% | -4.34% | +35.20% | +71.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.5B 54.78B 44.32B 40.72B 77.03B 5,224B 77.72B 521B 204B 2,606B 206B 201B 8,640B | 50.62B 58.38B 47.23B 43.4B 82.1B 5,568B 82.83B 556B 217B 2,778B 219B 214B 9,208B |
| Net income | 7.69B 8.87B 7.18B 6.59B 12.47B 846B 12.58B 84.41B 33.03B 422B 33.31B 32.57B 1,399B | 9.35B 10.79B 8.73B 8.02B 15.17B 1,029B 15.3B 103B 40.16B 513B 40.5B 39.6B 1,701B |
| Net Debt | 11.37B 13.11B 10.6B 9.74B 18.43B 1,250B 18.6B 125B 48.81B 624B 49.22B 48.13B 2,067B | 7.68B 8.85B 7.16B 6.58B 12.45B 844B 12.56B 84.23B 32.96B 421B 33.24B 32.5B 1,396B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | €74.32 | -0.40% | 3,409 |
| 26-08-03 | €74.62 | +0.62% | 4,864 |
| 26-07-31 | €74.16 | +1.87% | 8,353 |
| 26-07-30 | €72.80 | -8.86% | 16,594 |
| 26-07-29 | €79.88 | +0.36% | 2,946 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- 1SAN Stock
Select your edition
All financial news and data tailored to specific country editions
